Dirk Nagorsen

Dirk Nagorsen serves as the Chief Medical Officer at Cartography Biosciences since August 2025, having previously held the same title at Affini-T Therapeutics from July 2022 to August 2025. With extensive experience at Amgen, Dirk held various senior roles including Vice President of Early Development TA Head Oncology and Executive Medical Director for Early Development in Hematology/Oncology from March 2012 to June 2022. Prior positions include Senior Medical Director at Micromet AG, and academic roles such as Professor of Medicine at the University of Heidelberg and attending physician at Charite. Dirk's early career involved a postdoctoral fellowship at the NIH and research in oncology/immunology at Freie Universität Berlin. Academic qualifications include two MD degrees from Humboldt-Universität zu Berlin and Freie Universität Berlin, and a PhD/Habilitation in Experimental Medicine from Humboldt-Universität zu Berlin.